Sarepta Plunged After Adverse Event Forces Trial Halt in the UK Post author:Sam Post published:February 11, 2018 Post category:BioPharma But the biotech swiftly indicated that it doesn’t expect the halt to last for long. Source: BioSpace You Might Also Like Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year February 28, 2017 Basilea Snags Extended $226M+ Antifungal Deal With Pfizer November 30, 2017 BioProcess International Conference Brings Biotech Together in Boston September 21, 2017
